Cuprina Holdings is trading at $2.14, down 6.14%, in after-hours trading, with no clear new company-specific catalyst identified.
- The recent over-allotment closing raised approximately $745,629 from additional shares at $1.15 each; available coverage does not link it to the decline.
- BTC was near unchanged and ETH was down 0.35% over 24 hours, offering no clear matching crypto-market explanation.
- Cuprina is a biomedical company, rather than a crypto-focused business.